Novus Biologicals is an e-commerce and life sciences company that develops, licenses, and markets research materials to scientists in academic, corporate, and government laboratories. Since 1996, Novus Biologicals has partnered with leading scientific researchers and third-party providers to develop a portfolio of more than 100,000 products. These research tools provide investigators with high-quality antibodies, proteins, kits and RNAi for the study of protein functions in disease in the key fields of cancer, neuroscience, and metabolic disorders. Novus Biologicals has been included in Inc. magazine’s 500|5000 list as one of the fastest growing, privately held companies in the U.S. for the past seven years. Novus Biologicals was acquired by Bio-Techne in July 2014.
Add-on acquisitions since Mainsail Investment
Imgenex: Provider of specialized reagents for Life Science research (Acquired in October 2013)